Clinical Trial Update: YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness [Phase 3]

View source ↗

Summary

Phase 3 trial update for YM150 in preventing venous thromboembolism in patients with acute medical illness. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• YM150

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED